Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report

Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report

Summary

Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ultragenyx Pharmaceutical Inc. (Ultragenyx or ‘the company’) is a clinical-stage biopharmaceutical company. The company classifies its business into a single business: the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare diseases. The company’s marketed products include Crysvita for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO); Mepsevii for treatment of mucopolysaccharidosis VII (MPS VII, Sly syndrome); and Dojolvi for treatment of long-chain fatty acid oxidation disorders (LC-FAOD). It is also developing two pipeline products including, DTX301 for the treatment of ornithine transcarbamylase (OTC) deficiency; and DTX401 for treatment of glycogen storage disease type 1a (GSDIa). The company through its subsidiaries operates in the UK, Switzerland, the US, Germany, Brazil, Argentina, Netherlands, France, Colombia, Canada, and Mexico. Ultragenyx is headquartered in Novato, California, the US

Scope

• Detailed information on Ultragenyx Pharmaceutical Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Ultragenyx Pharmaceutical Inc. in the form of a SWOT analysis
• An in-depth view of the business model of Ultragenyx Pharmaceutical Inc. including a breakdown and examination of key business segments
• Intelligence on Ultragenyx Pharmaceutical Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Ultragenyx Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

• Gain understanding of Ultragenyx Pharmaceutical Inc. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Ultragenyx Pharmaceutical Inc. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Ultragenyx Pharmaceutical Inc.'s business structure, strategy and prospects.